Lymphomas: Related News

On Our Blog

DNA wrapped around histones
What Is Epigenetics?

Physician-scientist Omar Abdel-Wahab explains epigenetics, a growing field based on the study of genetic changes that are not part of the DNA code, and how it relates to cancer.

October 14, 2014
Transplant Patients Walk Hospital Halls to Support Bone Marrow Donation

Transplant patients at Memorial Sloan Kettering gave support to bone marrow donation efforts with their own “walk” inside the hospital.

September 25, 2014
Compound from Tropical Plant Targets Key Cancer-Causing Genes

Memorial Sloan Kettering researchers have found a naturally occurring compound that can destroy cancer cells in mice by targeting MYC, a cancer-causing gene that has remained elusive until now.

July 28, 2014
Pictured: Susan Prockop & Lucas T.
Wiping Out Epstein-Barr Virus Preserves Transplant Success

Memorial Sloan Kettering physician-scientists have prevented a dangerous complication of stem cell transplantation using immune cells donated from a third party.

March 6, 2014
Pictured: Sergio Giralt
Memorial Sloan Kettering’s Expertise Stands Out at Transplant Meeting

Memorial Sloan Kettering’s leadership in blood and marrow stem cell transplantation is on full display at the 2014 BMT Tandem Meeting.

February 26, 2014
Pictured: Steven M. Horwitz
What You Need to Know about Non-Hodgkin Lymphoma

A recent web chat features medical oncologist Steven M. Horwitz discussing advances in the diagnosis and treatment of lymphoma.

January 31, 2014
Pictured: Anas Younes, Joachim Yahalom & Ahmet Dogan
Watch Our Experts Discuss the Latest in Lymphoma Diagnosis and Treatment

Lymphoma experts at Memorial Sloan Kettering discuss new directions in the diagnosis and treatment of this type of cancer.

December 31, 2013
Pictured: Ross Levine
New Diagnostic Test for Blood Cancers Will Help Doctors Tailor Treatments

A new diagnostic test co-developed by Memorial Sloan Kettering identifies hundreds of genetic alterations in blood cancers, which will guide physicians in treatment decisions.

December 9, 2013
Pictured: Anas Younes, Chief, Lymphoma Service
At Work: Anas Younes, Chief of the Lymphoma Service

Medical oncologist Anas Younes leads an ambitious effort to find disease biomarkers that could predict which lymphoma patients will benefit from new targeted therapies.

October 30, 2013
Pictured: Sergio Giralt & Robin Roberts
Robin Roberts Celebrates with Fellow Stem Cell Transplant Recipients

Robin Roberts celebrated with more than 200 fellow stem cell transplant patients at Memorial Sloan Kettering’s annual Stem Cell Transplant Survivors Celebration.

October 17, 2013
Pictured: Andromachi Scaradavou
How Do I Decide Whether I Should Bank Cord Blood from My Newborn?

In this “Ask the Expert” feature, pediatric hematologist Andromachi Scaradavou discusses options for expectant parents who are considering banking a newborn’s cord blood.

July 24, 2013
Pictured: Sergio Giralt
Memorial Sloan Kettering’s One-Year Survival Rate after Allogeneic Bone Marrow Transplant Exceeds Expectations

Adult Bone Marrow Transplantation Service Chief Sergio Giralt explains recent advances that are enabling more patients to survive the most difficult period after receiving a transplant.

March 26, 2012
Pictured: Hans-Guido Wendel
Genetic Causes of Blood Cancers Explored

German-born cancer biologist Hans-Guido Wendel is taking advantage of transformative advances in genomics technology to understand key genetic abnormalities in leukemia and lymphoma.

December 20, 2011
Pictured: Mary McCabe
Cancer Survivorship: An Interview with Mary McCabe

In 2003, Mary McCabe was recruited to lead Memorial Sloan Kettering Cancer Center’s Cancer Survivorship Initiative and since that time has worked to develop a comprehensive program for cancer survivors, which includes follow-up care, research, and education and training.

July 1, 2011

Related Media Coverage

ASH 2013 Preview: CAR Modified T Cells, Novel Assays, and Ibrutinib

Hematologic Oncology Division Head Marcel van den Brink comments on abstracts being presented by Memorial Sloan Kettering physicians at the 2013 American Society of Hematology Annual Meeting and Exposition.

December 4, 2013